BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11023199)

  • 1. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
    Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
    Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
    Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
    Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM
    Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo.
    Asai A; Miyagi Y; Hashimoto H; Lee SH; Mishima K; Sugiyama A; Tanaka H; Mochizuki T; Yasuda T; Kuchino Y
    Cell Growth Differ; 1994 Nov; 5(11):1153-8. PubMed ID: 7848917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H
    Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M; Hofer MJ; Roth E; Pircher HP; Pagenstecher A
    J Neuropathol Exp Neurol; 2009 May; 68(5):525-34. PubMed ID: 19525900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
    Lefranc F; Cool V; Velu T; Brotchi J; De Witte O
    Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
    Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
    Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice.
    Provinciali M; Argentati K; Tibaldi A
    Gene Ther; 2000 Apr; 7(7):624-32. PubMed ID: 10819579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
    Li CH; Jiao BH
    Ai Zheng; 2007 Jan; 26(1):38-43. PubMed ID: 17222365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.